Cetera Investment Advisers Takes Position in Everus (NYSE:ECG)

Cetera Investment Advisers acquired a new position in shares of Everus (NYSE:ECGFree Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 15,908 shares of the company’s stock, valued at approximately $1,046,000.

Other hedge funds also recently modified their holdings of the company. SRS Capital Advisors Inc. bought a new position in shares of Everus during the 4th quarter valued at approximately $26,000. Principal Securities Inc. bought a new position in shares of Everus in the fourth quarter worth $27,000. HighMark Wealth Management LLC bought a new stake in Everus during the fourth quarter valued at approximately $28,000. Crews Bank & Trust bought a new position in Everus in the fourth quarter valued at $29,000. Finally, Quarry LP purchased a new position in shares of Everus during the 4th quarter valued at about $36,000.

Everus Stock Performance

NYSE:ECG opened at $56.80 on Friday. The company has a current ratio of 1.58, a quick ratio of 1.50 and a debt-to-equity ratio of 0.47. Everus has a 52 week low of $31.38 and a 52 week high of $77.93. The company’s 50 day moving average price is $43.02 and its 200-day moving average price is $54.45.

Everus (NYSE:ECGGet Free Report) last issued its quarterly earnings data on Tuesday, May 13th. The company reported $0.72 earnings per share for the quarter, topping the consensus estimate of $0.43 by $0.29. The business had revenue of $826.63 million during the quarter, compared to the consensus estimate of $676.35 million. The company’s revenue was up 32.1% on a year-over-year basis. As a group, sell-side analysts predict that Everus will post 2.49 earnings per share for the current year.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on ECG shares. DA Davidson increased their target price on Everus from $58.00 to $68.00 and gave the company a “neutral” rating in a report on Thursday, May 15th. Stifel Nicolaus upped their price target on Everus from $55.00 to $71.00 and gave the stock a “buy” rating in a research note on Friday, May 16th.

View Our Latest Stock Report on ECG

Insider Buying and Selling at Everus

In other Everus news, Director Edward A. Ryan bought 1,400 shares of the business’s stock in a transaction dated Tuesday, February 25th. The shares were purchased at an average price of $38.02 per share, with a total value of $53,228.00. Following the completion of the purchase, the director now owns 14,928 shares in the company, valued at $567,562.56. This represents a 10.35% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CFO Maximillian J. Marcy bought 1,300 shares of Everus stock in a transaction on Tuesday, February 25th. The stock was acquired at an average price of $38.99 per share, for a total transaction of $50,687.00. Following the purchase, the chief financial officer now owns 5,508 shares of the company’s stock, valued at approximately $214,756.92. This trade represents a 30.89% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders own 0.21% of the company’s stock.

About Everus

(Free Report)

Everus Construction Group is providing a full spectrum of construction services through its electrical and mechanical and transmission and distribution specialty contracting services principally in United States. Its specialty contracting services are provided to utility, transportation, commercial, industrial, institutional, renewable and other customers.

Featured Articles

Want to see what other hedge funds are holding ECG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Everus (NYSE:ECGFree Report).

Institutional Ownership by Quarter for Everus (NYSE:ECG)

Receive News & Ratings for Everus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Everus and related companies with MarketBeat.com's FREE daily email newsletter.